Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, ...

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

In terms of fundamentals, Omnicell has posted three quarters of increasing earnings growth. Revenue growth has also moved ...

Bill Holdings tried to break out ahead of earnings. The IBD 50 stock plunged 30% on earnings on Friday, triggering a sell ...

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the ...

Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD. Researchers from The ...